Indian Pediatr

1. SHASTRI DD, Dhir SK, Rajsekhar B, Nayak S, et al
   Indian Academy of Pediatrics (IAP) Advisory Committee on Vaccines and Immunization Practices (ACVIP): Recommended Immunization Schedule (2025) and Update on Immunization for Children Aged 0 Through 18 Years.
   Indian Pediatr. 2026 Apr 9. doi: 10.1007/s13312-026-00311.
   

   >> Share

   
   

   
   J Infect Dis

2. LEVY C, Dagan R, Bechet S, Cohen R, et al
   Is the interplay between maternal Tdap and pneumococcal conjugate vaccines relevant to infant pneumococcal carriage?
   J Infect Dis. 2026 Apr 6:jiag200. doi: 10.1093.
   

   >> Share

   
   

   
   N Engl J Med

3. PARDO-SECO J, Martinon-Torres F
   High-Dose Influenza Vaccine and Hospitalizations in Older Adults. Reply.
   N Engl J Med. 2026;394:1454.
   

   >> Share

   
   
4. JOHANSEN ND, Biering-Sorensen T
   High-Dose Influenza Vaccine and Hospitalizations in Older Adults. Reply.
   N Engl J Med. 2026;394:1454.
   

   >> Share

   
   
5. KANEDA Y, Fujikawa T
   High-Dose Influenza Vaccine and Hospitalizations in Older Adults.
   N Engl J Med. 2026;394:1453-1454.
   

   >> Share

   
   
6. CHEN HY, Liao JC, Yong SB
   High-Dose Influenza Vaccine and Hospitalizations in Older Adults.
   N Engl J Med. 2026;394:1453.
   

   >> Share

   
   
7. FEROLDI E, Mulligan MJ, Talaat KR, Tan CS, et al
   Immunogenicity and Safety of vYF, a Yellow Fever Vaccine - A Phase 2 Trial.
   N Engl J Med. 2026;394:1399-1408.
   

   >> Share

   
   

   
   Pediatrics

8. LABAN NM, Lee B
   Burden of Enteric Viral Infections Among United States Children in the Post-Rotavirus Vaccine Era.
   Pediatrics. 2026 Apr 9:e2025075045. doi: 10.1542/peds.2025-075045.
   

   >> Share

   
   
9. SZILAGYI PG, Gurfinkel D, Clark E, Albertin C, et al
   Clinician Perceptions of the Impact of Switching HPV Vaccine Initiation to 9-10 Years.
   Pediatrics. 2026 Apr 7:e2025074674. doi: 10.1542/peds.2025-074674.
   

   >> Share

   
   
10. OLSON SM, Ahmad HM, Wielgosz K, Michaels MG, et al
    Pediatric Vaccine Effectiveness Against Influenza Hospitalization And Outpatient Visits: 2021-2024.
    Pediatrics. 2026 Apr 6:e2025073973. doi: 10.1542/peds.2025-073973.
    

    >> Share

    
    
11. LUCACCIONI H, Maurel M, Perez-Gimeno G, Buda S, et al
    Influenza Vaccine Effectiveness in European Primary Care Pediatric Practices: 2022-2024.
    Pediatrics. 2026 Apr 6:e2025072907. doi: 10.1542/peds.2025-072907.
    

    >> Share

    
    
12. CHOW EJ, Berliner D, Page LC, Li-Vollmer M, et al
    The Meaning of Vaccine Effectiveness: Candid Communication About the Flu Shot.
    Pediatrics. 2026 Apr 6:e2025074682. doi: 10.1542/peds.2025-074682.
    

    >> Share

    
    

    
    PLoS One

13. QABAR CM, Roberts AW, Waldburger LM, Baidoo EEK, et al
    Leveraging a synthetic biology approach to enhance BCG-mediated expansion of Vgamma9Vdelta2 T cells.
    PLoS One. 2026;21:e0343925.
    

    >> Share

    
    
14. KALLAY R, Muhoza P, Tchoualeu DD, Fleming M, et al
    Perceptions of factors influencing Ebola vaccine acceptance among community members, healthcare workers, and response personnel in Eastern Democratic Republic of the Congo.
    PLoS One. 2026;21:e0346572.
    

    >> Share

    
    
15. SHUVO MN, Al Arian T, Fuad F, Noman MH, et al
    Computational and immunoinformatics approaches for designing phytocompound-based drugs and a multi-epitope vaccine targeting FemA, a cell wall protein of Staphylococcus aureus.
    PLoS One. 2026;21:e0346271.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

16. GUO S, Lei Q, Chen Y, Yang J, et al
    Oocyte-inspired universal whole-cell vaccines against tumor heterogeneity.
    Proc Natl Acad Sci U S A. 2026;123:e2520276123.
    

    >> Share

    
    

    
    Vaccine

17. CALDERWOOD LE, Schorpp S, Calhoun K, Mirza SA, et al
    Attitudes towards a potential future norovirus vaccine in a representative survey of U.S. adults, February 2025.
    Vaccine. 2026;80:128538.
    

    >> Share

    
    
18. AGRAWAL N, Mercedes R, Moulton EA, Sahni LC, et al
    Adherence to hepatitis B birth dose vaccine recommendations in two hospital systems in Houston.
    Vaccine. 2026;80:128564.
    

    >> Share

    
    
19. JESSICA B, Caroline S, Marie-Eve P
    Promoting vaccination in cardiovascular patients: a comprehensive scoping review of intervention strategies.
    Vaccine. 2026;80:128534.
    

    >> Share

    
    
20. STEPHENSEN CB, Huda MN, Alam MJ, Khanam A, et al
    Effects of neonatal Vitamin A supplementation on response to vaccinations in early infancy.
    Vaccine. 2026;80:128551.
    

    >> Share

    
    
21. PATEL K, Gautam M, Gairola S
    Comparative whole blood late-stage transcriptomics of polysaccharide and conjugated meningococcal serogroup A vaccine reveals distinct and persistent immune signatures in murine model.
    Vaccine. 2026;80:128537.
    

    >> Share

    
    
22. SIRARD JC, Cayet D, Fougeron D, Soulard D, et al
    Toll-like receptor 5 agonist is a potent adjuvant for intradermal vaccination.
    Vaccine. 2026;80:128543.
    

    >> Share

    
    
23. MORO PL, Romanson B, Marquez P, Zhang B, et al
    Adverse events after Pfizer's Respiratory Syncytial Virus Vaccine in pregnant women in the Vaccine Adverse Event Reporting System, 2024-2025, United States.
    Vaccine. 2026;80:128547.
    

    >> Share

    
    
24. MCCULLOUGH R, Reid A, Smyth D, O'Neill MT, et al
    Leadership matters: ward manager vaccination status influences nursing staff influenza vaccine uptake.
    Vaccine. 2026;80:128541.
    

    >> Share

    
    
25. DEBELLUT F, Constenla D, Mvundura M, Hausdorff WP, et al
    Economic evaluation of combination vaccines: Enabling a more comprehensive assessment of their benefits and challenges.
    Vaccine. 2026;80:128561.
    

    >> Share

    
    
26. WONGBORPHID S, Briggs EJ, Russell RA, Chowdhury S, et al
    Efficacy of a novel antigen-decorated adenoviral vaccine platform against porcine respiratory coronavirus infection in a large natural host.
    Vaccine. 2026;80:128556.
    

    >> Share

    
    
27. PICHON S, Bruyere I, Janicot S, Silhadi W, et al
    Safety and immunogenicity of a cytomegalovirus (CMV) recombinant glycoprotein B (gB) vaccine in combination with polyacrylate or an emulsion-based adjuvants.
    Vaccine. 2026;80:128553.
    

    >> Share

    
    
28. ZHANG J, Gong C, Xu Z, Han R, et al
    Multi-mode spatial accessibility to vaccination services and its impact on influenza-related hospitalisations among older adults.
    Vaccine. 2026;80:128540.
    

    >> Share

    
    

    
    Virus Res

29. XU M, Zhang C, Liu Y, Chen S, et al
    Corrigendum to"A noval strategy of deletion in PK gene for construction of a vaccine candidate with exellent safety and complete protection efficiency against high virulent Chinese pseudorabies virus variant" [Virus Research 313 (2022) 198740].
    Virus Res. 2026 Apr 8:199719. doi: 10.1016/j.virusres.2026.199719.
    

    >> Share

    
    
30. WU Y, Sun W, Xia Y, Feng Y, et al
    The influenza B virus candidate vaccine expressing H3 hemagglutinin developed in suspension MDCK cells confers protection against lethal H3N2 avian influenza in BALB/c mice.
    Virus Res. 2026;367:199722.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share